LambdaVision is a biotechnology company focused on developing a protein-based artificial retina to restore vision for patients with retinal degenerative diseases. They are pioneering the use of microgravity on the International Space Station (ISS) to improve the manufacturing process of these retinas. LambdaVision partners with organizations like NASA and Space Tango to conduct research and development in low Earth orbit, aiming for commercial-scale production of artificial retinas. Their work involves space-based manufacturing, microgravity research, and biomedical applications.
All verified mentions of this organization in source documents.
LambdaVision closed a $7 million seed round in November.
LambdaVision plans to produce artificial retinas, which are easier to manufacture in the microgravity environment of space.
LambdaVision announced the first closing of its seed round in May 2024.
LambdaVision is partnered with microgravity research firm Space Tango for its in-space manufacturing process.
LambdaVision is continuing to raise money in anticipation of its Series A funding.
LambdaVision has flown nine missions to the International Space Station (ISS) to produce a 200-layer protein thin film as a precursor to an artificial retina.
LambdaVision plans to scale up manufacturing in low Earth orbit (LEO) for artificial retinas.
LambdaVision closed a $7 million seed round on Wednesday.
LambdaVision won a NASA Phase 2 In Space Production Applications award in September to continue developing its in-space manufacturing process.
The funding will allow LambdaVision to continue operations through 2027.
LambdaVision continued research to produce an artificial retina using investigations on the International Space Station.
Space Tango launched an initial mission with LambdaVision to evaluate protein-based retinal implant production on orbit on the SpaceX Commercial Resupply Services-16 (CRS-16) mission from Cape Canaveral, Florida on 2018-12-05 at approximately 1:16 PM EST.
Space Tango is working with LambdaVision, a Farmington, Connecticut company, to test whether LambdaVision can produce retinal implants in microgravity.